RedHill Biopharma (RDHL) Enterprise Value: 2011-2024
Historic Enterprise Value for RedHill Biopharma (RDHL) over the last 14 years, with Dec 2024 value amounting to $1.9 million.
- RedHill Biopharma's Enterprise Value fell 115.92% to -$2.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$12.9 million, marking a year-over-year increase of 46.23%. This contributed to the annual value of $1.9 million for FY2024, which is 214.11% up from last year.
- As of FY2024, RedHill Biopharma's Enterprise Value stood at $1.9 million, which was up 214.11% from -$1.6 million recorded in FY2023.
- In the past 5 years, RedHill Biopharma's Enterprise Value registered a high of $247.8 million during FY2020, and its lowest value of -$13.6 million during FY2022.
- In the last 3 years, RedHill Biopharma's Enterprise Value had a median value of -$1.6 million in 2023 and averaged -$4.5 million.
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 115.02% in 2022, then soared by 214.11% in 2024.
- RedHill Biopharma's Enterprise Value (Yearly) stood at $247.8 million in 2020, then plummeted by 63.36% to $90.8 million in 2021, then slumped by 115.02% to -$13.6 million in 2022, then soared by 87.93% to -$1.6 million in 2023, then spiked by 214.11% to $1.9 million in 2024.